Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by LAVA Therapeutics N.V. LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference June 20, 2024 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Announces Annual Meeting of Shareholders June 10, 2024 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference May 30, 2024 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results May 21, 2024 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference May 06, 2024 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Provides Business Updates and Reports Fourth Quarter and Year-End Financial Results March 20, 2024 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd2/LAVA-1223) March 05, 2024 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA® January 25, 2024 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX Lava Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results November 16, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference September 06, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results August 22, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics to Participate in the H.C. Wainwright Immune Cell Engager Virtual Conference August 14, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics Provides Updates on Clinical Programs and Extends the Cash Runway June 14, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results June 08, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics Announces Selection by Janssen of Lead Gamma-Delta T-Cell Engager Bispecific Antibody to Move Toward Clinical Development June 01, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics to Participate in the Jefferies Healthcare Conference June 01, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Announces Annual Meeting of Shareholders May 30, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2022 Financial Results April 11, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics Announces Appointment of Christy J. Oliger to its Board of Directors March 09, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics Announces Initial Data from the Ongoing Phase 1/2a Clinical Trial of LAVA-1207 in Therapy Refractory mCRPC at the 2023 ASCO GU Symposium February 16, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics to Present at the 2023 SVB Securities Global Biopharma Conference February 09, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics Announces the Appointment of Dr. Charles Morris as Chief Medical Officer February 06, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics to Present LAVA-1207 Clinical Data at the 2023 ASCO GU Symposium January 23, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics Announces Appointment of New Directors to the Board January 06, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference January 03, 2023 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics Announces Updated Data from the Phase 1/2a Clinical Trial of LAVA-051 at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition December 10, 2022 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics Provides Business Update and Reports Third Quarter Financial Results November 16, 2022 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics to Present at the Jefferies London Healthcare Conference November 03, 2022 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics to Present Updated Data from the Phase 1/2a Clinical Trial of LAVA-051 at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition November 03, 2022 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX LAVA Therapeutics Announces Appointment of Fred M. Powell as Chief Financial Officer November 01, 2022 From LAVA Therapeutics N.V. Via GlobeNewswire Tickers LVTX Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.